Y-mAbs Therapeutics
YMAB
#8021
Rank
$0.21 B
Marketcap
$4.69
Share price
3.30%
Change (1 day)
-68.96%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Y-mAbs Therapeutics CIK: 0001722964

Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Y-mAbs Therapeutics
 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)